Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

NCT06232304 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2025-10-30

No results posted yet for this study

Summary

This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.

Conditions

  • Systemic Lupus Erythematosus of Childhood (Disorder)

Interventions

BEHAVIORAL

TEACH

TEACH is a cognitive behavioral coping skills program. It consists of six one-hour weekly sessions that are conducted either in-person or remotely.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • The Hospital for Sick Children

    collaborator OTHER
  • Seattle Children's Hospital

    collaborator OTHER
  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER
  • Tulane University

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • Helen DeVos Children's Hospital

    collaborator OTHER
  • Montefiore Medical Center

    collaborator OTHER
  • Michigan State University

    lead OTHER

Principal Investigators

  • Natoshia R Cunningham, PhD · Michigan State University

  • Andrea Knight, MD, MSCE · The Hospital for Sick Children

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-12
Primary Completion
2027-04-01
Completion
2027-09-30

Countries

  • United States
  • Canada

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06232304 on ClinicalTrials.gov